Expert insights. Personalized for you.
AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. MORE
Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC. MORE
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. The post Jazz Pharmaceuticals Increases Guidance Based On GW Pharma Acquisition appeared first on Green Market Report. MORE
Here’s a quick blurb……… The rapid growth of cannabis-based medicines is becoming a significant disruptor of the global pharmaceutical industry, but the point of … Read More. MORE
The post MGC Pharmaceuticals acquires Australian telehealth platform Medicinal Cannabis Clinics first appeared on Cannabis Law Report. MORE
The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the British economy for over 20 years—but also how much it so far has been reserved, as an industry, and as a drug, for the elite. GW Pharmaceuticals was just awarded a so-called “ Queen’s Prize for Innovation.” . GW Pharmaceuticals in other words, may have just taken home a prestigious prize—and established itself as a global cannabis player. MORE
More Women Switch Out Pharmaceuticals For Medical Marijuana. The post More Women Switch Out Pharmaceuticals For Medical Marijuana appeared first on The Fresh Toast. Medical Marijuana News Endometriosis gynecology menopause pharmaceuticals prescription drugs women MORE
Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 The post Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025 – Cannabis Business Executive – Cannabis and Marijuana industry news. MORE
Clever Leaves Partners with Leading European Pharmaceutical Company to Market EU-GMP Certified Medical Cannabis Products NEW YORK, March 17, 2021… Read More. MORE
Because of its broad range of effects, cannabis can cause a variety of interactions with pharmaceutical drugs. The post How does cannabis interact with pharmaceutical drugs? A drug interaction happens when two or more compounds come in contact with each other and create an effect. MORE
AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB) (“Anebulo” or the “Company”), a clinical-stage biotechnology company developing novel solutions for people… Read More. Business Wire MORE
Endocannabinoid drug development company Corbus Pharmaceuticals Holdings, Inc. The post Corbus Pharmaceuticals Beats Estimates For Fourth Quarter appeared first on Cannabis Law Report. NASDAQ: CRBP) reported financial results for the fourth quarter and year-end 2020.… MORE
GW Pharmaceuticals lost $8 million in its latest quarter – an improvement over the previous three-month period – but the United Kingdom-based medical cannabinoid company … Read More. MORE
Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. MORE
The post Jazz Pharmaceuticals Pick Up GW Pharma For A Cool $7.2 For those of you living under a rock here is the news. We thought we better report it along with… Read More. billion first appeared on Cannabis Law Report. Breaking News MORE
Consumers Are Replacing Pharmaceuticals With Medical Marijuana In recent years, certain states that have medical and/or recreational cannabis programs in place have experienced decreases in the number of opioid overdoses. The post Consumers Are Replacing Pharmaceuticals With Medical Marijuana appeared first on The Fresh Toast. Cannabis Medical Marijuana News opioids pharmaceuticals MORE
BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Supera-CBD is MyMD’s pre-clinical patented synthetic cannabidiol (CBD) derivative that is being developed as a pharmaceutical drug to address anxiety, pain, and neurodegeneration. About MyMD Pharmaceuticals, Inc. MORE
Users are looking for safer alternatives to opioids, antidepressants, and arthritis relief. Green Entrepreneur MORE
BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing… Read More. Business Wire MORE
BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution effective after the US market opens on June 28, according to a preliminary list of additions posted June 4. About MyMD Pharmaceuticals, Inc. MORE
VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “Company”… Read More. Cannabis Finance News MORE
“Looking at the industry as it is growing, we are seeing the emergence of a brand-new sector: the psycheceutical industry, which merges the best of psychedelics and the best of pharmaceuticals. MORE
BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms. MORE
BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, will present at the H.C. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. MORE
BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today reported that its subsidiary Oravax Medical Inc. MORE
The post February 4 2021: Jazz Pharmaceuticals buys GW Pharma for $7.2 … Read More. billion first appeared on Cannabis Law Report. Cannabis Law TV MORE
BALTIMORE–(BUSINESS WIRE)– $MYMD — MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. MORE
Under the terms of the agreement OCT will use reasonable efforts to develop and commercialise: (i) at least one CBD derivative; (ii) at least one CBG derivative; and (iii) at least one THC derivative, as pharmaceutical drug products. Oxford Cannabinoid Technologies Holdings plc. . MORE
The post February 4 2021: Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 … Read More. billion first appeared on Cannabis Law Report. Cannabis Law TV MORE
Authors. Michael Sassano. When tackling your computer systems, software, and quality control processes, keep in mind. that there are many paths to travel, and the smartest way is to go piece by piece as your. company grows. You will find that there are diverse softwares for various sectors of your. MORE
The platform was specifically designed to power the traceability of testing standards within the legal cannabis, nutraceutical, food and pharmaceutical space with a focus on the authentication of source materials or ingredients used in formulation. MORE
Algernon Pharmaceuticals Inc. CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“Algernon”), a clinical stage pharmaceutical development company, is pleased to announce… Read More. MORE
–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. About Marinus Pharmaceuticals. Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders. MORE
While other cannabis industry SPAC’s have seemed to make big splashy entrances to the market, Ibere Pharmaceuticals quietly closed on… Read More. The post Ibere Pharmaceuticals Is The Quiet SPAC first appeared on Cannabis Law Report. MORE
About GW Pharmaceuticals Limited GW Pharmaceuticals (GW), a subsidiary of Jazz Pharmaceuticals plc, has established a world-leading position in cannabinoid science and medicine. GW was acquired by Jazz Pharmaceuticals in May 2021. MORE
Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol “MYMD“ Upon… Read More. Business Wire MORE
In Europe, there is a clear trend towards the use of more precise formulations of unapproved cannabis products as well as pharmaceutical products. The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space. MORE
Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed ex-GW Pharmaceuticals CFO… Read More. MORE
Pharmaceutical Related Topics 
Cannabis Life Network
MARCH 31, 2021
Because of its broad range of effects, cannabis can cause a variety of interactions with pharmaceutical drugs. The post How does cannabis interact with pharmaceutical drugs? A drug interaction happens when two or more compounds come in contact with each other and create an effect.
The Fresh Toast
NOVEMBER 21, 2020
More Women Switch Out Pharmaceuticals For Medical Marijuana. The post More Women Switch Out Pharmaceuticals For Medical Marijuana appeared first on The Fresh Toast. Medical Marijuana News Endometriosis gynecology menopause pharmaceuticals prescription drugs women
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MARCH 9, 2021
While other cannabis industry SPAC’s have seemed to make big splashy entrances to the market, Ibere Pharmaceuticals quietly closed on… Read More. The post Ibere Pharmaceuticals Is The Quiet SPAC first appeared on Cannabis Law Report.
Cannabis Law Report
MARCH 15, 2021
Endocannabinoid drug development company Corbus Pharmaceuticals Holdings, Inc. The post Corbus Pharmaceuticals Beats Estimates For Fourth Quarter appeared first on Cannabis Law Report. NASDAQ: CRBP) reported financial results for the fourth quarter and year-end 2020.…
Cannabis Law Report
SEPTEMBER 2, 2021
In Europe, there is a clear trend towards the use of more precise formulations of unapproved cannabis products as well as pharmaceutical products. The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space.
Cannabis Law Report
MAY 12, 2021
BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing… Read More. Business Wire
Cannabis Law Report
MARCH 18, 2021
Clever Leaves Partners with Leading European Pharmaceutical Company to Market EU-GMP Certified Medical Cannabis Products NEW YORK, March 17, 2021… Read More.
Cannabis Law Report
JUNE 17, 2021
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. The post Jazz Pharmaceuticals Increases Guidance Based On GW Pharma Acquisition appeared first on Green Market Report.
Cannabis Law Report
JULY 23, 2021
Users are looking for safer alternatives to opioids, antidepressants, and arthritis relief. Green Entrepreneur
Cannabis Law Report
AUGUST 10, 2021
BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today reported that its subsidiary Oravax Medical Inc.
Cannabis Law Report
JUNE 7, 2021
BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution effective after the US market opens on June 28, according to a preliminary list of additions posted June 4. About MyMD Pharmaceuticals, Inc.
|
Cannabis Law Report
MAY 12, 2020
GW Pharmaceuticals lost $8 million in its latest quarter – an improvement over the previous three-month period – but the United Kingdom-based medical cannabinoid company … Read More.
Cannabis Law Report
APRIL 13, 2021
Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed ex-GW Pharmaceuticals CFO… Read More.
Cannabis Law Report
APRIL 16, 2021
Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol “MYMD“ Upon… Read More. Business Wire
Cannabis Law Report
MARCH 20, 2021
Algernon Pharmaceuticals Inc. CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“Algernon”), a clinical stage pharmaceutical development company, is pleased to announce… Read More.
Cannabis Law Report
MAY 6, 2021
AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB) (“Anebulo” or the “Company”), a clinical-stage biotechnology company developing novel solutions for people… Read More. Business Wire
Cannabis Law Report
JULY 7, 2021
BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms.
Cannabis Law Report
FEBRUARY 3, 2021
The post February 4 2021: Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 … Read More. billion first appeared on Cannabis Law Report. Cannabis Law TV
Cannabis Law Report
SEPTEMBER 8, 2021
The platform was specifically designed to power the traceability of testing standards within the legal cannabis, nutraceutical, food and pharmaceutical space with a focus on the authentication of source materials or ingredients used in formulation.
Cannabis Law Report
FEBRUARY 3, 2021
The post February 4 2021: Jazz Pharmaceuticals buys GW Pharma for $7.2 … Read More. billion first appeared on Cannabis Law Report. Cannabis Law TV
Cannabis Law Report
AUGUST 24, 2021
BALTIMORE–(BUSINESS WIRE)– $MYMD — MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.
Cannabis Law Report
FEBRUARY 3, 2021
The post Jazz Pharmaceuticals Pick Up GW Pharma For A Cool $7.2 For those of you living under a rock here is the news. We thought we better report it along with… Read More. billion first appeared on Cannabis Law Report. Breaking News
Cannabis Law Report
OCTOBER 20, 2020
Here’s a quick blurb……… The rapid growth of cannabis-based medicines is becoming a significant disruptor of the global pharmaceutical industry, but the point of … Read More.
Cannabis Law Report
AUGUST 10, 2021
About GW Pharmaceuticals Limited GW Pharmaceuticals (GW), a subsidiary of Jazz Pharmaceuticals plc, has established a world-leading position in cannabinoid science and medicine. GW was acquired by Jazz Pharmaceuticals in May 2021.
Cannabis Law Report
APRIL 28, 2021
Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.
Cannabis Law Report
JULY 5, 2021
Authors. Michael Sassano. When tackling your computer systems, software, and quality control processes, keep in mind. that there are many paths to travel, and the smartest way is to go piece by piece as your. company grows. You will find that there are diverse softwares for various sectors of your.
Cannabis Law Report
NOVEMBER 23, 2020
The post MGC Pharmaceuticals acquires Australian telehealth platform Medicinal Cannabis Clinics first appeared on Cannabis Law Report.
Cannabis Law Report
AUGUST 22, 2021
“Looking at the industry as it is growing, we are seeing the emergence of a brand-new sector: the psycheceutical industry, which merges the best of psychedelics and the best of pharmaceuticals.
Cannabis Law Report
AUGUST 17, 2021
–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. About Marinus Pharmaceuticals. Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders.
Cannabis Law Report
MAY 11, 2021
VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “Company”… Read More. Cannabis Finance News
Cannabis Law Report
OCTOBER 5, 2021
AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc.
Cannabis Law Report
SEPTEMBER 9, 2021
BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, will present at the H.C. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.
Cannabis Law Report
SEPTEMBER 22, 2021
Under the terms of the agreement OCT will use reasonable efforts to develop and commercialise: (i) at least one CBD derivative; (ii) at least one CBG derivative; and (iii) at least one THC derivative, as pharmaceutical drug products. Oxford Cannabinoid Technologies Holdings plc. .
SpeedWeed
SEPTEMBER 3, 2021
Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 The post Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025 – Cannabis Business Executive – Cannabis and Marijuana industry news.
Cannabis Law Report
OCTOBER 19, 2021
BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Supera-CBD is MyMD’s pre-clinical patented synthetic cannabidiol (CBD) derivative that is being developed as a pharmaceutical drug to address anxiety, pain, and neurodegeneration. About MyMD Pharmaceuticals, Inc.
SpeedWeed
JUNE 15, 2021
The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the British economy for over 20 years—but also how much it so far has been reserved, as an industry, and as a drug, for the elite. GW Pharmaceuticals was just awarded a so-called “ Queen’s Prize for Innovation.” . GW Pharmaceuticals in other words, may have just taken home a prestigious prize—and established itself as a global cannabis player.
Veriheal
AUGUST 12, 2021
Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC.
40 
Let's personalize your content